AUTHOR INDEX

Browse by letter:
 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Search results for: "V"
Results 71 - 80 of 260 shown below
Vargas, Francisco
Ursula Wyneken, Mauricio Sandoval, Soledad Sandoval, Franscisco Jorquera, Ignacio González, Francisco Vargas, Romina Falcon, Milena Monari and Fernando Orrego
Clinically Relevant Doses of Fluoxetine and Reboxetine Induce Changes in the TrkB Content of Central Excitatory Synapses
doi:10.1038/sj.npp.1301052
Neuropsychopharmacology 31, 2415-2423

Abstract | Full text | PDF |
Vargas, Gabriel A
Jonathan D Urban, Gabriel A Vargas, Mark von Zastrow and Richard B Mailman
Aripiprazole has Functionally Selective Actions at Dopamine D2 Receptor-Mediated Signaling Pathways
doi:10.1038/sj.npp.1301071
Neuropsychopharmacology 32, 67-77

Abstract | Full text | PDF |
Varghese, George
Samuel P Lee, Zhidong Xie, George Varghese, Tuan Nguyen, Brian F O'Dowd and Susan R George
Oligomerization of Dopamine and Serotonin Receptors
doi:10.1016/S0893-133X(00)00155-X
Neuropsychopharmacology 23, S32-S40

Abstract | PDF |
Varney, Mark A
Daniel S Lorrain, Hervé Schaffhauser, Una C Campbell, Christopher S Baccei, Lucia D Correa, Blake Rowe, Dana E Rodriguez, Jeffery J Anderson, Mark A Varney, Anthony B Pinkerton, Jean-Michel Vernier and Linda J Bristow
Group II mGlu Receptor Activation Suppresses Norepinephrine Release in the Ventral Hippocampus and Locomotor Responses to Acute Ketamine Challenge
doi:10.1038/sj.npp.1300238
Neuropsychopharmacology 28, 1622-1632

Abstract | Full text | PDF |
Chris S Busse, Jesse Brodkin, David Tattersall, Jeffery J Anderson, Noelle Warren, Lida Tehrani, Linda J Bristow, Mark A Varney and Nicholas DP Cosford
The Behavioral Profile of the Potent and Selective mGlu5 Receptor Antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in Rodent Models of Anxiety
doi:10.1038/sj.npp.1300540
Neuropsychopharmacology 29, 1971-1979

Abstract | Full text | PDF |
Varoquaux, Odile
Isabelle Arnulf, Philippe Quintin, Jean-Claude Alvarez, Laurence Vigil, Yvan Touitou, Anne-Sophie Lèbre, Agnès Bellenger, Odile Varoquaux, Jean-Philippe Derenne, Jean-François Allilaire, Chawki Benkelfat and Marion Leboyer
Mid-morning Tryptophan Depletion Delays REM Sleep Onset in Healthy Subjects
doi:10.1016/S0893-133X(02)00358-5
Neuropsychopharmacology 27, 843-851

Abstract | Full text | PDF |
Vartian, Nina
Oliver Kudlacek, Herwig Just, Vladimir M Korkhov, Nina Vartian, Markus Klinger, Halyna Pankevych, Qiong Yang, Christian Nanoff, Michael Freissmuth and Stefan Boehm
The Human D2 Dopamine Receptor Synergizes with the A2A Adenosine Receptor to Stimulate Adenylyl Cyclase in PC12 Cells
doi:10.1038/sj.npp.1300181
Neuropsychopharmacology 28, 1317-1327

Abstract | Full text | PDF |
Varty, Geoffrey B
Neal R Swerdlow, Geoffrey B Varty and Mark A Geyer
Discrepant Findings of Clozapine Effects on Prepulse Inhibition of Startle: Is It the Route or the Rat?
doi:10.1016/S0893-133X(97)00110-3
Neuropsychopharmacology 18, 50-56

Abstract | PDF |
Geoffrey B Varty, Vaishali P Bakshi, Mark A Geyer and Geoffrey B Varty
M100907, a Serotonin 5-HT2A Receptor Antagonist and Putative Antipsychotic, Blocks Dizocilpine-Induced Prepulse Inhibition Deficits in Sprague–Dawley and Wistar Rats
doi:10.1016/S0893-133X(98)00072-4
Neuropsychopharmacology 20, 311-321

Abstract | Full text | PDF |
Geoffrey B Varty, Vaishali P Bakshi, Mark A Geyer and Geoffrey B Varty
M100907, a Serotonin 5-HT2A Receptor Antagonist and Putative Antipsychotic, Blocks Dizocilpine-Induced Prepulse Inhibition Deficits in Sprague–Dawley and Wistar Rats
doi:10.1016/S0893-133X(98)00072-4
Neuropsychopharmacology 20, 311-321

Abstract | Full text | PDF |
Mark A Geyer, Kirsten Krebs-Thomson and Geoffrey B Varty
The Effects of M100907 in Pharmacological and Developmental Animal Models of Prepulse Inhibition Deficits in Schizophrenia
doi:10.1038/sj.npp.1395447
Neuropsychopharmacology 21, S134-S142

Abstract | PDF |
Geoffrey B Varty, Cynthia A Morgan, Mary E Cohen-Williams, Vicki L Coffin and Galen J Carey
The Gerbil Elevated Plus-Maze I: Behavioral Characterization and Pharmacological Validation
doi:10.1016/S0893-133X(02)00312-3
Neuropsychopharmacology 27, 357-370

Abstract | Full text | PDF |
Geoffrey B Varty, Mary E Cohen-Williams, Cynthia A Morgan, Ursula Pylak, Ruth A Duffy, Jean E Lachowicz, Galen J Carey and Vicki L Coffin
The Gerbil Elevated Plus-maze II: Anxiolytic-like Effects of Selective Neurokinin NK1 Receptor Antagonists
doi:10.1016/S0893-133X(02)00313-5
Neuropsychopharmacology 27, 371-379

Abstract | Full text | PDF |
Varvel, Stephen A
Stephen A Varvel, Laura E Wise, Floride Niyuhire, Benjamin F Cravatt and Aron H Lichtman
Inhibition of Fatty-Acid Amide Hydrolase Accelerates Acquisition and Extinction Rates in a Spatial Memory Task
doi:10.1038/sj.npp.1301224
Neuropsychopharmacology 32, 1032-1041

Abstract | Full text | PDF |
Vasek, Jitka
Ann M Rasmusson, Jitka Vasek, Deborah S Lipschitz, Dolores Vojvoda, Mary Ellen Mustone, Quihu Shi, Gretchen Gudmundsen, Charles A Morgan, Jessica Wolfe and Dennis S Charney
An Increased Capacity for Adrenal DHEA Release is Associated with Decreased Avoidance and Negative Mood Symptoms in Women with PTSD
doi:10.1038/sj.npp.1300432
Neuropsychopharmacology 29, 1546-1557

Abstract | Full text | PDF |
Vasilaki, Anna
Eleftherios Pallis, Anna Vasilaki, Dominique Fehlmann, Andreas Kastellakis, Daniel Hoyer, Christina Spyraki and Kyriaki Thermos
Antidepressants Influence Somatostatin Levels and Receptor Pharmacology in Brain
doi:10.1038/npp.2008.133
Neuropsychopharmacology 34, 952-963

Abstract | Full text | PDF |
Result page | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | previous Previous | Next next
  top go to top

Extra navigation

.
ADVERTISEMENT